OGN — Organon & Co. stock price, charts and financials

QT69Organon & Co.

Organon & Co. (NYSE: OGN) is a Healthcare company in the Drug Manufacturers - General industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
13.56
+0.00%
OverviewShort InterestFilings
OGNQT69Organon & Co.·NYSE
13.56+0.00%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 20268-KCurrent report
Jul 31, 202610-QQuarterly report
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 23, 20268-KCurrent report
Jul 17, 20268-KCurrent report
Jul 17, 2026DEFA14AAdditional proxy soliciting materials
Jun 17, 2026DEFM14ADefinitive proxy statement (merger)
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 11, 2026DEFA14AAdditional proxy soliciting materials
Jun 11, 20268-KCurrent report
Jun 01, 2026PREM14APREM14A
May 29, 2026SDSpecialized disclosure report
May 07, 20264/AStatement of changes in beneficial ownership (amended)
May 07, 20264Statement of changes in beneficial ownership
May 04, 202610-QQuarterly report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 381
Page
▼
/ 16